Literature DB >> 27358881

Philadelphia chromosome-negative acute myeloid leukemia with 11q23/MLL translocation in a patient with chronic myelogenous leukemia.

Vanya Jaitly1, Wei Wang1, Shimin Hu1.   

Abstract

Although defined by the presence of t(9;22), chronic myelogenous leukemia (CML) can have other concurrent additional cytogenetic changes, especially during disease progression. Additional chromosomal changes (ACAs) in CML often occur in Philadelphia chromosome (Ph)-positive cells and are associated with disease acceleration and treatment resistance. Occasionally chromosomal changes occur in Ph-negative cells and this phenomenon is often transient and does not correlate with disease progression. Very rarely myelodysplastic syndrome or acute leukemia can develop in Ph-negative cells. In this study, we report an unusual case of acute myeloid leukemia (AML) with 11q23/MLL translocation emerging from Ph-negative cells in a patient with CML.

Entities:  

Keywords:  11q23; MLL; Philadelphia chromosome (Ph)-negative AML; chronic myelogenous leukemia (CML)

Year:  2015        PMID: 27358881      PMCID: PMC4923655          DOI: 10.3978/j.issn.2306-9759.2015.06.01

Source DB:  PubMed          Journal:  Stem Cell Investig        ISSN: 2306-9759


  21 in total

Review 1.  Philadelphia-negative acute lymphoblastic leukemia developing in a CML patient in imatinib mesylate-induced complete cytogenetic remission.

Authors:  S Cherrier-De Wilde; K Rack; P Vannuffel; A Delannoy; A Hagemeijer
Journal:  Leukemia       Date:  2003-10       Impact factor: 11.528

2.  Fatal myelodysplastic syndrome developing during therapy with imatinib mesylate and characterised by the emergence of complex Philadelphia negative clones.

Authors:  Y L Chee; M A Vickers; D Stevenson; T L Holyoake; D J Culligan
Journal:  Leukemia       Date:  2003-03       Impact factor: 11.528

3.  A positive role for c-Abl in Atm and Atr activation in DNA damage response.

Authors:  X Wang; L Zeng; J Wang; J F L Chau; K P Lai; D Jia; A Poonepalli; M P Hande; H Liu; G He; L He; B Li
Journal:  Cell Death Differ       Date:  2010-08-27       Impact factor: 15.828

4.  Development of AML with t(8;21)(q22;q22) and RUNX1-RUNX1T1 fusion following Philadelphia-negative clonal evolution during treatment of CML with Imatinib.

Authors:  Philippe Schafhausen; Judith Dierlamm; Carsten Bokemeyer; Tim H Bruemmendorf; Ulrike Bacher; Axel R Zander; Susanne Schnittger; Andreas Hochhaus
Journal:  Cancer Genet Cytogenet       Date:  2009-02

5.  Development of acute myeloid leukemia associated with Ph-negative clone with inv(3)(q21q26) during imatinib therapy for chronic myeloid leukemia.

Authors:  Pavel Dvorak; Martina Hruba; Ivan Subrt
Journal:  Leuk Res       Date:  2008-11-01       Impact factor: 3.156

Review 6.  De novo acute myeloid leukemia associated with t(11;17)(q23;q25) and MLL-SEPT9 rearrangement in an elderly patient: a case study and review of the literature.

Authors:  Sang-Guk Lee; Tae Sung Park; Seung Hwan Oh; Ji Chan Park; Young Joon Yang; Rolf Marschalek; Claus Meyer; Eun Hae Cho; So Young Shin
Journal:  Acta Haematol       Date:  2011-08-16       Impact factor: 2.195

7.  Chromosomal abnormalities in Philadelphia chromosome negative metaphases appearing during imatinib mesylate therapy in patients with newly diagnosed chronic myeloid leukemia in chronic phase.

Authors:  Elias Jabbour; Hagop M Kantarjian; Lynne V Abruzzo; Susan O'Brien; Guillermo Garcia-Manero; Srdan Verstovsek; Jianqin Shan; Mary Beth Rios; Jorge Cortes
Journal:  Blood       Date:  2007-07-11       Impact factor: 22.113

Review 8.  Acute lymphoblastic leukemia without the Philadelphia chromosome occurring in chronic myelogenous leukemia with the Philadelphia chromosome.

Authors:  Hee Jin Huh; Jung Won Huh; Chu Myong Seong; Miae Lee; Wha Soon Chung
Journal:  Am J Hematol       Date:  2003-11       Impact factor: 10.047

9.  Chromosomal rearrangement involving 11q23 locus in chronic myelogenous leukemia: a rare phenomenon frequently associated with disease progression and poor prognosis.

Authors:  Wei Wang; Guilin Tang; Jorge E Cortes; Hui Liu; Di Ai; C Cameron Yin; Shaoying Li; Joseph D Khoury; Carlos Bueso-Ramos; L Jeffrey Medeiros; Shimin Hu
Journal:  J Hematol Oncol       Date:  2015-04-08       Impact factor: 17.388

10.  The MLL recombinome of acute leukemias in 2013.

Authors:  C Meyer; J Hofmann; T Burmeister; D Gröger; T S Park; M Emerenciano; M Pombo de Oliveira; A Renneville; P Villarese; E Macintyre; H Cavé; E Clappier; K Mass-Malo; J Zuna; J Trka; E De Braekeleer; M De Braekeleer; S H Oh; G Tsaur; L Fechina; V H J van der Velden; J J M van Dongen; E Delabesse; R Binato; M L M Silva; A Kustanovich; O Aleinikova; M H Harris; T Lund-Aho; V Juvonen; O Heidenreich; J Vormoor; W W L Choi; M Jarosova; A Kolenova; C Bueno; P Menendez; S Wehner; C Eckert; P Talmant; S Tondeur; E Lippert; E Launay; C Henry; P Ballerini; H Lapillone; M B Callanan; J M Cayuela; C Herbaux; G Cazzaniga; P M Kakadiya; S Bohlander; M Ahlmann; J R Choi; P Gameiro; D S Lee; J Krauter; P Cornillet-Lefebvre; G Te Kronnie; B W Schäfer; S Kubetzko; C N Alonso; U zur Stadt; R Sutton; N C Venn; S Izraeli; L Trakhtenbrot; H O Madsen; P Archer; J Hancock; N Cerveira; M R Teixeira; L Lo Nigro; A Möricke; M Stanulla; M Schrappe; L Sedék; T Szczepański; C M Zwaan; E A Coenen; M M van den Heuvel-Eibrink; S Strehl; M Dworzak; R Panzer-Grümayer; T Dingermann; T Klingebiel; R Marschalek
Journal:  Leukemia       Date:  2013-04-30       Impact factor: 11.528

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.